Mediators of Inflammation
Volume 2009 (2009), Article ID 389720, 9 pages
doi:10.1155/2009/389720
Research Article

Effects of Methotrexate on Plasma Cytokines and Cardiac Remodeling and Function in Postmyocarditis Rats

Zhengang Zhang,1,2,3 Pei Zhao,1 Aihua Li,1 Xiaolei Lv,1 Yang Gao,1 Hongguang Sun,4 Yongling Ding,5 and Jian Liu6

1Department of Cardiovascular Disease, The First People's Hospital of Yangzhou, 45 Taizhou Road, Yangzhou, Jiangsu 225001, China
2Division of Internal Medicine, Department of Medicine, Yangzhou University, 11 Huaihai Road, Yangzhou, Jiangsu 225001, China
3Cardiovascular Institute Southeast University at Yangzhou, 45 Taizhou Road, Yangzhou, Jiangsu 225001, China
4Department of Ultrasonography, The First People's Hospital of Yangzhou, 45 Taizhou Road, Yangzhou, Jiangsu 225001, China
5Department of Pathology, The First People's Hospital of Yangzhou, 45 Taizhou Road, Yangzhou, Jiangsu 225001, China
6Central Lab, The First People's Hospital of Yangzhou, 45 Taizhou Road, Yangzhou, Jiangsu 225001, China

Received 6 February 2009; Revised 5 May 2009; Accepted 5 August 2009

Academic Editor: Tânia Fröde

Copyright © 2009 Zhengang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Mosterd and A. W. Hoes, “Clinical epidemiology of heart failure,” Heart, vol. 93, no. 9, pp. 1137–1146, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. K. Z. Gong, G. Song, J. P. Spiers, E. J. Kelso, and Z. G. Zhang, “Activation of immune and inflammatory systems in chronic heart failure: novel therapeutic approaches,” International Journal of Clinical Practice, vol. 61, no. 4, pp. 611–621, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson, “Autonomic imbalance and immune activation in chronic heart failure-pathophysiological links,” Cardiovascular Research, vol. 70, no. 3, pp. 434–445, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Blum and H. Miller, “Pathophysiological role of cytokines in congestive heart failure,” Annual Review of Medicine, vol. 52, pp. 15–27, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Valgimigli, C. Ceconi, P. Malagutti, et al., “Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study,” Circulation, vol. 111, no. 7, pp. 863–870, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. N. Sivasubramanian, M. L. Coker, K. M. Kurrelmeyer, et al., “Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor,” Circulation, vol. 104, no. 7, pp. 826–831, 2001. View at Scopus
  7. M. Faircloth, J. Clark, K. Dighe, and M. Marber, “The effects of chronic TNF-α administration in C57/BL6 mice,” Heart, vol. 92, supplement 2, 2006, pA71.
  8. F. Wolfe and K. Michaud, “Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy,” The American Journal of Medicine, vol. 116, no. 5, pp. 305–311, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. R. Nishio, A. Matsumori, T. Shioi, H. Ishida, and S. Sasayama, “Treatment of experimental viral myocarditis with interleukin-10,” Circulation, vol. 100, no. 10, pp. 1102–1108, 1999. View at Scopus
  10. A. P. Bolger, R. Sharma, S. von Haehling, et al., “Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure,” The American Journal of Cardiology, vol. 90, no. 4, pp. 384–389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Stumpf, C. Lehner, A. Yilmaz, W. G. Daniel, and C. D. Garlichs, “Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure,” Clinical Science, vol. 105, no. 1, pp. 45–50, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. D. Prabhu, B. Chandrasekar, D. R. Murray, and G. L. Freeman, “β-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling,” Circulation, vol. 101, no. 17, pp. 2103–2109, 2000. View at Scopus
  13. R. J. E. M. Dolhain, P. P. Tak, B. A. C. Dijkmans, P. De Kuiper, F. C. Breedveld, and A. M. M. Miltenburg, “Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis,” British Journal of Rheumatology, vol. 37, no. 5, pp. 502–508, 1998. View at Scopus
  14. D. E. Furst, “The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases,” British Journal of Rheumatology, vol. 36, no. 11, pp. 1196–1204, 1997. View at Scopus
  15. Z. Yuan, C. Kishimoto, K. Shioji, H. Nakamura, J. Yodoi, and S. Sasayama, “Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression,” Cardiovascular Research, vol. 55, no. 2, pp. 320–328, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Genestier, R. Paillot, S. Fournel, C. Ferraro, P. Miossec, and J.-P. Revillard, “Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells,” The Journal of Clinical Investigation, vol. 102, no. 2, pp. 322–328, 1998. View at Scopus
  17. R. B. Devereux and N. Reichek, “Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method,” Circulation, vol. 55, no. 4, pp. 613–618, 1977. View at Scopus
  18. N. Nagaya, K. Kangawa, T. Itoh, et al., “Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy,” Circulation, vol. 112, no. 8, pp. 1128–1135, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. O. Yokoseki, J.-I. Suzuki, H. Kitabayashi, et al., “Cis element decoy against nuclear factor-κB attenuates development of experimental autoimmune myocarditis in rats,” Circulation Research, vol. 89, no. 10, pp. 899–906, 2001. View at Scopus
  20. H. Futamatsu, J. Suzuki, N. Koga, et al., “A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivation,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 6, pp. 853–861, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Gong, Z. Zhang, X. Sun, et al., “The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure,” American Heart Journal, vol. 151, no. 1, pp. 62–68, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. Pathak, S. Sarkar, E. Vellaichamy, and S. Sen, “Role of myocytes in myocardial collagen production,” Hypertension, vol. 37, no. 3, pp. 833–840, 2001. View at Scopus
  23. W. Liu, W.-M. Li, C. Gao, and N.-L. Sun, “Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats,” Journal of Autoimmunity, vol. 25, no. 4, pp. 258–263, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. P. Krishnamurthy, J. Rajasingh, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore, “IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR,” Circulation Research, vol. 104, no. 2, pp. e9–e18, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. E. M. Dalmarco, T. S. Fröde, and Y. S. Medeiros, “Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy,” Mediators of Inflammation, vol. 11, no. 5, pp. 299–306, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Johnston, J. E. Gudjonsson, H. Sigmundsdottir, B. R. Ludviksson, and H. Valdimarsson, “The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules,” Clinical Immunology, vol. 114, no. 2, pp. 154–163, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus